Variable/category | Nº of tested cats (%) | N° of positive cats (%) | ||||||
---|---|---|---|---|---|---|---|---|
Anaplasma/Ehrlichia | Babesia | Bartonella | B. burgdorferi s.l. | Hepatozoon | Leishmania | ≥ 1 positive PCR | ||
Gender | 649 | |||||||
Female | 372 (57.3) | 18 (4.8) | 31 (8.3) | 11 (3.0) | 9 (2.4) | 32 (8.6) | 44 (11.8) | 122 (32.8) |
Male | 277 (42.7) | 17 (6.1) | 12 (4.3) | 8 (2.9) | 5 (1.8) | 24 (8.7) | 20 (7.2) | 72 (26.0) |
Breed | 484 | |||||||
DSH | 432 (89.3) | 22 (5.1) | 22 (5.1)* | 10 (2.3) | 4 (0.9) | 31 (7.2) | 33 (7.6) | 109 (25.2) |
Other breed | 52 (10.7) | 1 (1.9) | 10 (19.2)* | 2 (3.8) | 1 (1.9) | 3 (5.8) | 7 (13.5) | 19 (36.5) |
Lifestyle | 649 | |||||||
Domestic | 320 (49.3) | 9 (2.8)* | 28 (8.8)* | 5 (1.6) | 3 (0.9) | 24 (7.5) | 33 (10.3) | 91 (28.4) |
Stray | 329 (50.7) | 26 (7.9)* | 15 (4.6)* | 14 (4.3) | 11 (3.3) | 32 (9.7) | 31 (9.4) | 103 (31.3) |
Age (months) | 462 | |||||||
[3-11] | 129 (27.9) | 5 (3.9) | 13 (10.1) | 4 (3.1) | 1 (0.8) | 3 (2.3)* | 6 (4.7)a | 27 (20.9) |
[12-59] | 216 (46.8) | 10 (4.6) | 13 (6.0) | 6 (2.8) | 0 (0.0) | 17 (7.9) | 14 (6.5)b | 54 (25.0) |
[60-228] | 117 (25.3) | 5 (4.3) | 5 (4.3) | 0 (0.0) | 2 (1.7) | 11 (9.4)* | 16 (13.7)a,b | 35 (29.9) |
Acaricides-insecticides | 568 | |||||||
Yes | 204 (35.9) | 5 (2.5) | 4 (2.0)* | 3 (1.5) | 3 (1.5) | 11 (5.4)* | 27 (13.2)* | 51 (25.0)* |
No | 364 (64.1) | 22 (6.0) | 37 (10.2)* | 16 (4.4) | 10 (2.7) | 42 (11.5)* | 28 (7.7)* | 126 (34.6)* |
Region | 649 | |||||||
Lisbon | 386 (59.5) | 18 (4.7) | 9 (2.3)* | 8 (2.1) | 3 (0.8)* | 25 (6.5)* | 31 (8.0) | 85 (22.0)* |
Algarve | 263 (40.5) | 17 (6.5) | 34 (12.9)* | 11 (4.2) | 11 (4.2)* | 31 (11.8)* | 33 (12.5) | 109 (41.4)* |
Habitat | 649 | |||||||
Urban | 282 (43.5) | 18 (6.4) | 8 (2.8)* | 4 (1.4) | 0 (0.0) | 14 (5.0)* | 9 (3.2)* | 47 (16.7)* |
Rural | 367 (56.5) | 17 (4.6) | 35 (9.5)* | 15 (4.1) | 14 (3.8) | 42 (11.4)* | 55 (15.0)* | 147 (40.1)* |
Housing | 589 | |||||||
Totally indoors | 124 (21.1) | 3 (2.4) | 6 (4.8) | 1 (0.8) | 0 (0.0) | 3 (2.4)* | 13 (10.5) | 24 (19.4)* |
Access to outdoors | 465 (78.9) | 28 (6.0) | 36 (7.7) | 17 (3.7) | 8 (1.7) | 51 (11.0)* | 39 (8.4) | 151 (32.5)* |
FeLV | 242 | |||||||
Negative | 231 (95.5) | 12 (5.2) | 15 (6.5) | 6 (2.6) | 6 (2.6) | 13 (5.6) | 29 (12.6) | 70 (30.3) |
Positive | 11 (4.5) | 1 (9.1) | 1 (9.1) | 0 (0.0) | 1 (9.1) | 1 (9.1) | 0 (0.0) | 3 (27.3) |
FIV | 247 | |||||||
Negative | 226 (91.5) | 11 (4.9) | 16 (7.1) | 6 (2.7) | 6 (2.7) | 14 (6.2) | 28 (12.4) | 69 (30.5) |
Positive | 21 (8.5) | 3 (14.3) | 1 (4.8) | 0 (0.0) | 1 (4.8) | 1 (4.8) | 1 (4.8) | 6 (28.6) |
Clinical status | 222 | |||||||
Non-suspect | 197 (88.7) | 8 (4.1) | 26 (13.2) | 1 (0.5) | 0 (0.0) | 12 (6.1) | 8 (4.1) | 49 (24.9) |
Suspect | 25 (11.3) | 3 (12.0) | 1 (4.0) | 0 (0.0) | 0 (0.0) | 1 (4.0) | 3 (12.0) | 6 (24.0) |
Total | 649 (100) | 35 (5.4) | 43 (6.6) | 19 (2.9) | 14 (2.2) | 56 (8.6) | 64 (9.9) | 194 (29.9) |